2 June 2023

Last updated: Monday 29 May 2023

Research Directory

Step up the fight against superbugs, says EU

European Commission highlights access, supply in pharma proposal

Development timelines for new oncology drugs

Swiss companies weather the turmoil in 2022

HIV vaccine remains elusive but antivirals deliver value

FDA guides on accelerated approvals in oncology

Stock values decline and companies restructure

Oncology pipeline marked by multiple therapy types

After three years of Covid, risks to health remain

Novel oncology drugs approved in a year of change